Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wierda Toxicology Consulting is a specialized non-clinical safety and toxicology consultancy firm based in Indiana, USA. Led by Dr. Daniel Wierda, a Fellow of the Academy of Toxicological Sciences, the company provides expert services in immunotoxicology, immunogenicity assessment, and preclinical drug development. The firm supports biotechnology and pharmaceutical companies in designing and evaluating safety studies for a wide range of therapeutic modalities, including small molecules and monoclonal antibodies. Wierda Toxicology Consulting is particularly recognized for its expertise in assessing the potential adverse effects of novel therapeutics on the immune system and navigating regulatory requirements for IND and NDA submissions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wierda Toxicology.